Modellbiblioteket openEHR Fork
Name
Pharmacogenetic gene profile
Description
Details of cumulative pharmacogenetic phenotype findings relating to a single gene, in particular to record metaboliser status / functional activity against an enzyme known to impact the effectiveness/ toxicity of one or more medications.
As individual pharmacogenetic tests may provide only incomplete allele testing, this archetype is intended to act as an overall cumulative representation of tall individual tests, from which therapeutic recommendations should be derived.
Keywords
pharmacogenetics
pharmacogenomics
decision support
contraindication
precaution
pgx.
Purpose
To record details of pharmacogenetic phenotype findings relating to a single genotype, in particular to record metaboliser status / functional activity against an enzyme known to impact the effectiveness/ toxicity of one or more medications.
As individual pharmacogenetic tests may provide only incomplete allele testing, this archetype is intended to act as an overall cumulative representation of tall individual tests, from which therapeutic recommendations should be derived.
Use
There is crossover in purpose with the Precaution archetype https://ckm.openehr.org/ckm/archetypes/1013.1.2593, but this is designed to record many different therapeutic precautions, and to report only adverse effects e.g poor efficacy or toxicity, whereas this archetype is intended to capture both positive and negative effects and normal metaboliser status.
In that respect this is perhaps closer to a a diagnosis then a risk factor or precaution.
There is an argument that Precaution might be used to flag the presence of significant phenotypes, perhaps as a general statement such as 'Significant known metaboliser issues' which reference the specific Phenotypic records.
The main content is intended to be carried in a slotted CLUSTER Pharmacogenetics analyte result archetype=, but in this context to record the cumulative results and not that of a single test.
In that respect this is perhaps closer to a a diagnosis then a risk factor or precaution.
There is an argument that Precaution might be used to flag the presence of significant phenotypes, perhaps as a general statement such as 'Significant known metaboliser issues' which reference the specific Phenotypic records.
The main content is intended to be carried in a slotted CLUSTER Pharmacogenetics analyte result archetype=, but in this context to record the cumulative results and not that of a single test.
Misuse
Not to be used to record genomic phenotypes which are unrelated to pharmacogenetics, such as molecular genomics reports to support cancer care.
References
HL7.FHIR.UV.GENOMICS-REPORTING\Genomics Background - FHIR v4.0.1 "HL7.FHIR.UV.GENOMICS-REPORTING\Genomics Background - FHIR V4.0.1". Build.Fhir.Org, 2023, http://build.fhir.org/ig/HL7/genomics-reporting/background.html. Accessed 7 Mar 2023.
Dolin, R., Boxwala, A. and Shalaby, J. Dolin, R.H. et al. "A Pharmacogenomics Clinical Decision Support Service Based On FHIR And CDS Hooks". Methods Of Information In Medicine, vol 57, no. S 02, 2018, pp. e115-e123. Georg Thieme Verlag KG, doi:10.1055/s-0038-1676466. Accessed 7 Mar 2023.
Cpicpgx.Org, 2023, http://cpicpgx.org/wp-content/uploads/2016/02/CPIC-Term-Standardization-and-LOINC-151203.pdf. Accessed 22 May 2023.
Archetype Id
openEHR-EHR-EVALUATION.pharmacogenetic_gene_profile.v0
Copyright
© Apperta Foundation, openEHR Foundation
Licencing
This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.
Original Author
Ian McNicoll
freshEHR Clinical Informatics Ltd.
freshEHR Clinical Informatics Ltd.
Date Originally Authored
To record details of pharmacogenetic phenotype findings relating to a single genotype, in particular to record metaboliser status / functional activity against an enzyme known to impact the effectiveness/ toxicity of one or more medications.
As individual pharmacogenetic tests may provide only incomplete allele testing, this archetype is intended to act as an overall cumulative representation of tall individual tests, from which therapeutic recommendations should be derived.
Name | Card | Type | Description |
---|---|---|---|
Pharmacogenetic profile
|
0..1 | Slot (Cluster) |
Slot to include details of the genotype which relates to this phenotype.
Slot
Slot
|
Name | Card | Type | Description |
---|---|---|---|
Date assessed
|
0..1 | DV_DATE_TIME |
The date at which the phenotype was assessed.
DV_DATE_TIME
|
Original result
|
0..* | DV_EHR_URI |
Details of those people who helped me to complete this record.
DV_EHR_URI
|
Extension
|
0..* | Slot (Cluster) |
Additional information required to capture local content or to align with other reference models/formalisms.
Slot
Slot
|
archetype (adl_version=1.4; uid=88d12437-d75a-40e7-99ac-6d25061d1bdc) openEHR-EHR-EVALUATION.pharmacogenetic_gene_profile.v0 concept [at0000] -- Pharmacogenetic gene profile language original_language = <[ISO_639-1::en]> description original_author = < ["name"] = <"Ian McNicoll"> ["organisation"] = <"freshEHR Clinical Informatics Ltd."> ["email"] = <"ian@freshehr.com"> ["date"] = <"2023-03-02"> > details = < ["en"] = < language = <[ISO_639-1::en]> purpose = <"To record details of pharmacogenetic phenotype findings relating to a single genotype, in particular to record metaboliser status / functional activity against an enzyme known to impact the effectiveness/ toxicity of one or more medications. As individual pharmacogenetic tests may provide only incomplete allele testing, this archetype is intended to act as an overall cumulative representation of tall individual tests, from which therapeutic recommendations should be derived."> use = <"There is crossover in purpose with the Precaution archetype https://ckm.openehr.org/ckm/archetypes/1013.1.2593, but this is designed to record many different therapeutic precautions, and to report only adverse effects e.g poor efficacy or toxicity, whereas this archetype is intended to capture both positive and negative effects and normal metaboliser status. In that respect this is perhaps closer to a a diagnosis then a risk factor or precaution. There is an argument that Precaution might be used to flag the presence of significant phenotypes, perhaps as a general statement such as 'Significant known metaboliser issues' which reference the specific Phenotypic records. The main content is intended to be carried in a slotted CLUSTER Pharmacogenetics analyte result archetype=, but in this context to record the cumulative results and not that of a single test."> keywords = <"pharmacogenetics, pharmacogenomics, decision support, contraindication, precaution, pgx.", ...> misuse = <"Not to be used to record genomic phenotypes which are unrelated to pharmacogenetics, such as molecular genomics reports to support cancer care."> copyright = <"© Apperta Foundation, openEHR Foundation"> > > lifecycle_state = <"in_development"> other_contributors = <> other_details = < ["licence"] = <"This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/."> ["custodian_organisation"] = <"openEHR Foundation"> ["references"] = <"HL7.FHIR.UV.GENOMICS-REPORTING\\Genomics Background - FHIR v4.0.1 \"HL7.FHIR.UV.GENOMICS-REPORTING\\Genomics Background - FHIR V4.0.1\". Build.Fhir.Org, 2023, http://build.fhir.org/ig/HL7/genomics-reporting/background.html. Accessed 7 Mar 2023. Dolin, R., Boxwala, A. and Shalaby, J. Dolin, R.H. et al. \"A Pharmacogenomics Clinical Decision Support Service Based On FHIR And CDS Hooks\". Methods Of Information In Medicine, vol 57, no. S 02, 2018, pp. e115-e123. Georg Thieme Verlag KG, doi:10.1055/s-0038-1676466. Accessed 7 Mar 2023. Cpicpgx.Org, 2023, http://cpicpgx.org/wp-content/uploads/2016/02/CPIC-Term-Standardization-and-LOINC-151203.pdf. Accessed 22 May 2023."> ["original_namespace"] = <"org.openehr"> ["original_publisher"] = <"openEHR Foundation"> ["custodian_namespace"] = <"org.openehr"> ["MD5-CAM-1.0.1"] = <"5770759C24BACD3D3F49506A5F774BC2"> ["build_uid"] = <"5d0a752f-a2e2-4f12-9308-aae97d6e8617"> ["ip_acknowledgements"] = <"This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyrighted material of the International Health Terminology Standards Development Organisation (IHTSDO). Where an implementation of this artefact makes use of SNOMED CT content, the implementer must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/snomed-ct/get-snomed or info@snomed.org."> ["revision"] = <"0.0.1-alpha"> > definition EVALUATION[at0000] matches { -- Pharmacogenetic gene profile data matches { ITEM_TREE[at0001] matches { -- Item tree items cardinality matches {0..*; unordered} matches { allow_archetype CLUSTER[at0003] occurrences matches {0..1} matches { -- Pharmacogenetic profile include archetype_id/value matches {/.*/} } } } } protocol matches { ITEM_TREE[at0015] matches { -- Item tree items cardinality matches {0..*; unordered} matches { ELEMENT[at0016] occurrences matches {0..1} matches { -- Date assessed value matches { DV_DATE_TIME matches {*} } } ELEMENT[at0030] occurrences matches {0..*} matches { -- Original result value matches { DV_EHR_URI matches {*} } } allow_archetype CLUSTER[at0017] occurrences matches {0..*} matches { -- Extension include archetype_id/value matches {/.*/} } } } } } ontology terminologies_available = <"SNOMED-CT", "LOINC"> term_definitions = < ["en"] = < items = < ["at0000"] = < text = <"Pharmacogenetic gene profile"> description = <"Details of cumulative pharmacogenetic phenotype findings relating to a single gene, in particular to record metaboliser status / functional activity against an enzyme known to impact the effectiveness/ toxicity of one or more medications. As individual pharmacogenetic tests may provide only incomplete allele testing, this archetype is intended to act as an overall cumulative representation of tall individual tests, from which therapeutic recommendations should be derived."> > ["at0001"] = < text = <"Item tree"> description = <"@ internal @"> > ["at0003"] = < text = <"Pharmacogenetic profile"> description = <"Slot to include details of the genotype which relates to this phenotype."> > ["at0015"] = < text = <"Item tree"> description = <"@ internal @"> > ["at0016"] = < text = <"Date assessed"> description = <"The date at which the phenotype was assessed."> > ["at0017"] = < text = <"Extension"> description = <"Additional information required to capture local content or to align with other reference models/formalisms."> > ["at0030"] = < text = <"Original result"> description = <"Details of those people who helped me to complete this record."> > > > > term_bindings = < ["SNOMED-CT"] = < items = < ["at0030"] = <[SNOMED-CT::3331000181100]> > > ["LOINC"] = < items = < ["at0030"] = <[LOINC::LA10315-2]> > > >